Köröskényi et al., 1961 - Google Patents
Human vascular antigen complement consumption test of hypertensive patients (preliminary report)Köröskényi et al., 1961
- Document ID
- 3177448657891427600
- Author
- Köröskényi K
- Juba F
- Vajda G
- Publication year
- Publication venue
- Experientia
External Links
Snippet
Der «Gefässantigentest»(complement-consumption-test) wurde bei 122 hypertonischen Kranken, bei 44 verschiedenen internen Patienten und bei 41 gesunden Personen durchgeführt. Das Ergebnis war bei den Hypertonikern in 49, 1%, bei den Internen in 16, 1 …
- 230000000295 complement 0 title description 11
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Witebsky et al. | Chronic thyroiditis and autoimmunization | |
| Minick et al. | Experimental induction of atheroarteriosclerosis by the synergy of allergic injury to arteries and lipid-rich diet: II. Effect of repeatedly injected foreign protein in rabbits fed a lipid-rich, cholesterol-poor diet | |
| VOLPÉ et al. | THE PATHOGENESIS OF GRAVES'DISEASE AND HASHIMOTO'S THYROIDITIS | |
| Fillios et al. | Experimental production of gross atherosclerosis in the rat | |
| Hess et al. | Transfer of an autoimmune nephrosis in the rat by means of lymph node cells | |
| Gitlin et al. | Synthesis of α-fetoprotein by liver, yolk sac, and gastrointestinal tract of the human conceptus | |
| Miller | Etiology and pathogenesis of mouse leukemia | |
| BRAVO et al. | Musculoskeletal disorders after renal homotransplantation: A clinical and laboratory analysis of 60 cases | |
| Sherlock | Chronic hepatitis | |
| Banan et al. | Protection against ethanol injury by prostaglandin in a human intestinal cell line: role of microtubules | |
| JP2022095884A (en) | Pharmaceutical composition for preventing or treating rheumatoid arthritis comprising isolated mitochondria | |
| Köröskényi et al. | Human vascular antigen complement consumption test of hypertensive patients (preliminary report) | |
| Mohamed et al. | Deletion of Thioredoxin-interacting protein ameliorates high fat diet-induced non-alcoholic steatohepatitis through modulation of Toll-like receptor 2-NLRP3-inflammasome axis: histological and immunohistochemical study | |
| Kream et al. | Origin of 25-hydroxyvitamin D3 binding protein from tissue cytosol preparations | |
| Krakauer et al. | Prostaglandin E1 treatment of NZB/W mice: III. Preservation of spleen cell concentrations and mitogen-induced proliferative responses | |
| Bacon et al. | Cell-mediated immunity to synovial antigens in rheumatoid arthritis | |
| Jordan | Development of sheep thymus in relation to in utero thymectomy experiments | |
| Andrada et al. | Experimental thyroiditis in the rhesus monkey. IV. The role of thyroglobulin and cellular antigens | |
| Gryshchenko et al. | Marker changes of blood plasma proteinogram in rats with toxic hepatitis | |
| Russfield et al. | Serum protein patterns associated with amyloidosis in the Syrian hamster | |
| Sugie et al. | Inhibition by Dietary Benzylselenocyanate of Hepatocarcinogenesis Induced by Azoxymethane in Fischer 344 Rats 1 | |
| Rowell | Systemic Sclerosis: The Watson Smith Lecture 1984 | |
| Knobloch et al. | An estimation of the nature of nucleoproteins by an analytical method | |
| Genovese et al. | Effect of thalidomide on signal transduction pathways and secondary damage in experimental spinal cord trauma | |
| Rose | Thyroid autoimmunity: a voyage of discovery |